Larimar Therapeutics LRMR
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q3 | 3.23 | 103.75 | -0.61 | -49,500 | -48 | |
| 2025Q2 | 2.89 | 106.15 | -0.41 | -27,791 | -26 | |
| 2025Q1 | 2.15 | 106.51 | -0.46 | -31,188 | -29 | |
| 2024Q4 | 3.87 | 108.57 | -0.46 | -31,293 | -29 | |
| 2024Q3 | 6.55 | 117.84 | -0.24 | -18,264 | -15 | |
| 2024Q2 | 7.25 | 113.74 | -0.35 | -24,599 | -22 | |
| 2024Q1 | 7.59 | 114.19 | -0.27 | -16,734 | -15 | |
| 2023Q4 | 4.55 | 109.00 | -0.29 | -14,162 | -13 | |
| 2023Q3 | 3.95 | 114.07 | -0.21 | -10,339 | -9 | |
| 2023Q2 | 3.13 | 114.99 | -0.19 | -9,620 | -8 | |
| 2023Q1 | 4.53 | 117.02 | -0.15 | -7,637 | -7 | |
| 2022Q4 | 4.13 | 110.76 | -0.05 | -10,439 | -9 | |
| 2022Q3 | 3.20 | 102.32 | -0.36 | -8,513 | -8 | |
| 2022Q2 | 1.96 | 100.23 | -0.47 | -8,687 | -9 | |
| 2022Q1 | 4.05 | 99.37 | -0.49 | -8,887 | -9 | |
| 2021Q4 | 10.79 | 99.47 | -0.47 | -9,086 | -9 | |
| 2021Q3 | 11.53 | 99.55 | -0.94 | -16,730 | -17 | |
| 2021Q2 | 9.82 | 99.48 | -0.78 | -12,543 | -13 | |
| 2021Q1 | 14.61 | 100.15 | -0.76 | -12,106 | -12 | |
| 2020Q4 | 21.41 | 101.35 | -0.88 | -14,396 | -14 |